Validation of the postnatal growth and retinopathy of prematurity screening criteria

• Published in: Proceedings - Baylor University. Medical Center Vol. 33; no. 4; pp. 546 - 549
• Main Authors: Wadley, Sean, Recko, Matthew, Samson, Shoji
• Format: Journal Article
• Language: English
• Published: Dallas Taylor & Francis Ltd 01-10-2020; Taylor & Francis
• Subjects: Case Report; Cost control; Diabetic retinopathy; Eye diseases; Original Research; Visual impairment; United States > US; Texas
• ISSN: 0899-8280; 1525-3252
• DOI: 10.1080/08998280.2020.1793709

The objective of this study was to validate the generalizability of the Postnatal Growth and Retinopathy of Prematurity Study screening criteria in a new cohort of infants at risk for retinopathy of prematurity (ROP). This retrospective validation study conducted at a single academic medical center included 484 infants at risk for ROP born between January 14, 2014, and December 21, 2019. The primary outcomes evaluated were sensitivity for both type 1 and type 2 ROP, as defined by the Early Treatment of Retinopathy of Prematurity Study, as well as the reduction in total number of infants requiring ROP examinations. Secondary outcomes included the total number of ROP examinations avoided and the potential cost reduction of eliminating these examinations. In a cohort of 484 infants at risk for ROP, the criteria identified 40 of 40 (100%, 95% confidence interval 91.19%-100%) type 1 ROP cases and 27 of 27 (100%, 95% confidence interval 87.23%-100%) type 2 ROP cases while reducing the total number of infants screened by 35.7%. The Postnatal Growth and Retinopathy of Prematurity Study criteria were found in this study to be generalizable to a cohort of infants at a single teaching institution in central Texas. If applied during the studied interval, these criteria could have significantly reduced the number of infants undergoing ROP examinations and maintained excellent sensitivity for type 1 ROP.